Skip navigation

Develop Technology-Driven Partnerships that Revolutionize Patient Engagement and Data Management and Ensure Effective Clinical Trials

December 13-14, 2017
  • Philadelphia, PA

The biopharma industry overwhelmingly relies upon paper forms when collecting clinical outcomes data. Though this is a time-tested and familiar technique, it carries the risk of delivering compromised, or otherwise unusable data. The transition to e-Patient Reported Outcomes and e-Clinical Outcomes Assessment techniques can eliminate these data quality challenges.

At CBI’s eCOA/ePRO 2017, experts in clinical operations and outcomes research pinpoint the best ways to overcome logistical and organizational obstacles and speed up the adoption of far more efficient technology.

Issues to be Addressed Include:

  • The digital future of eCOA & ePRO —
    Innovative new technologies and their implementation
  • Standardization of data collected —
    How to ensure efficiency and consistency across devices, developing intuitive user interface and appropriately leveraging the cloud
  • Choosing the research instruments that work best in an e-format and managing that transition
  • Proving the superior long-term ROI of eCOA use and improving uptake throughout organizations and the industry
  • Optimizing training, translation, and tech-support systems
  • Improving patient adherence, data capture, and quality of submission packages to regulators

Download the Conference Preview

PREVIOUS ATTENDEE ACCLAIM:

High quality, inspiring and insightful conference that pinpoints important topics in the field of eCOA.

HEOR Scientist, Astrazeneca

An informative and engaging conference that not only highlighted the many facets of the featured topic but also explored other pertinent industry related issues.

LV Research Analyst, Corporate Translations

December 13-14, 2017 DoubleTree by Hilton Philadelphia, PA

eCOA/ePRO 2017

Develop Technology-Driven Partnerships that Revolutionize Patient Engagement and Data Management and Ensure Effective Clinical Trials

The biopharma industry overwhelmingly relies upon paper forms when collecting clinical outcomes data. Though this is a time-tested and familiar technique, it carries the risk of delivering compromised, or otherwise unusable data. The transition to e-Patient Reported Outcomes and e-Clinical Outcomes Assessment techniques can eliminate these data quality challenges.

At CBI’s eCOA/ePRO 2017, experts in clinical operations and outcomes research pinpoint the best ways to overcome logistical and organizational obstacles and speed up the adoption of far more efficient technology.

Issues to be Addressed Include:

  • The digital future of eCOA & ePRO —
    Innovative new technologies and their implementation
  • Standardization of data collected —
    How to ensure efficiency and consistency across devices, developing intuitive user interface and appropriately leveraging the cloud
  • Choosing the research instruments that work best in an e-format and managing that transition
  • Proving the superior long-term ROI of eCOA use and improving uptake throughout organizations and the industry
  • Optimizing training, translation, and tech-support systems
  • Improving patient adherence, data capture, and quality of submission packages to regulators

Download the Conference Preview

PREVIOUS ATTENDEE ACCLAIM:

High quality, inspiring and insightful conference that pinpoints important topics in the field of eCOA.

HEOR Scientist, Astrazeneca

An informative and engaging conference that not only highlighted the many facets of the featured topic but also explored other pertinent industry related issues.

LV Research Analyst, Corporate Translations

December 13-14, 2017 DoubleTree by Hilton Philadelphia, PA